Development and Validation of ‘Prediction of Adverse Drug Reactions in Older Inpatients (PADROI)’ Risk Assessment Tool

References

• Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ (Clinical Research Ed.) 2004;329(7456):15–19. doi:10.1136/bmj.329.7456.15
   PubMed Web of Science ®Google Scholar
• UMC-WHO. Safety Monitoring of Medicinal Products: Guidelines for Setting Up and Running a Pharmacovigilance Centre. WHO Collaborating Centre for International Drug Monitoring; 2000: 28.
   Google Scholar
• Seddon C. Reporting adverse drug reactions A guide for healthcare professionals. BMA 2006.
   Google Scholar
• Rabiu A, Simbak N, Haque M. A Systematic Review of Knowledge, Attitude and Practice on Adverse Drug Reactions and Pharmacovigilance Among Doctors. J Appl Pharm Sci. 2014; 4(11): 117-127.
   Google Scholar
• Yadesa TM, Kitutu FE, Deyno S, Ogwang PE, Tamukong R, Alele PE. Prevalence, characteristics and predicting risk factors of adverse drug reactions among hospitalized older adults: a systematic review and meta-analysis. SAGE Open Med. 2021;9:20503121211039099. doi:10.1177/20503121211039099
   Web of Science ®Google Scholar
• Lavan AH, Gallagher P. Predicting risk of adverse drug reactions in older adults. Ther Advan Drug Saf. 2016;7(1):11–22. doi:10.1177/2042098615615472
   PubMed Web of Science ®Google Scholar
• Jennings E, Gallagher P, O’Mahony D. Detection and prevention of adverse drug reactions in multi-morbid older patients. Age Ageing. 2019;48(1):10–13. doi:10.1093/ageing/afy157
   PubMed Web of Science ®Google Scholar
• Toll DB, Janssen KJ, Vergouwe Y, Moons KG. Validation, updating and impact of clinical prediction rules: a review. J Clin Epidemiol. 2008;61(11):1085–1094. doi:10.1016/j.jclinepi.2008.04.008
   PubMed Web of Science ®Google Scholar
• Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thor Oncol. 2010;5(9):1315–1316. doi:10.1097/JTO.0b013e3181ec173d
   PubMed Web of Science ®Google Scholar
• Tangiisuran B, Scutt G, Stevenson J, et al. Development and validation of a risk model for predicting adverse drug reactions in older people during hospital stay: Brighton Adverse Drug Reactions Risk (BADRI) model. PLoS One. 2014;9(10):e111254.
   PubMed Web of Science ®Google Scholar
• Pencina MJ, D’Agostino RB Sr. Evaluating discrimination of risk prediction models: the C statistic. JAMA. 2015;314(10):1063–1064. doi:10.1001/jama.2015.11082
   PubMed Web of Science ®Google Scholar
• Fawcett T. An introduction to ROC analysis. Pattern Recognit Lett. 2006;27(8):861–874. doi:10.1016/j.patrec.2005.10.010
   Web of Science ®Google Scholar
• Trevethan R. Sensitivity, specificity, and predictive values: foundations, pliabilities, and pitfalls in research and practice. Front Public Health. 2017;5:307. doi:10.3389/fpubh.2017.00307
   PubMed Web of Science ®Google Scholar
• Fischer JE, Bachmann LM, Jaeschke R. A readers’ guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med. 2003;29(7):1043–1051. doi:10.1007/s00134-003-1761-8
   PubMed Web of Science ®Google Scholar
• Hosmer DW Jr, Lemeshow S, Sturdivant RX. Applied Logistic Regression. Vol. 398. John Wiley & Sons; 2013.
   Google Scholar
• Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta paediatrica. 2007;96(5):644–647. doi:10.1111/j.1651-2227.2006.00178.x
   PubMed Web of Science ®Google Scholar
• Onder G, Petrovic M, Tangiisuran B, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. JAMA Intern Med. 2010;170(13):1142–1148.
   Web of Science ®Google Scholar
• O’Mahony D, O’Connor MN, Eustace J, Byrne S, Petrovic M, Gallagher P. The adverse drug reaction risk in older persons (ADRROP) prediction scale: derivation and prospective validation of an ADR risk assessment tool in older multimorbid patients. Eur Geriatr Med. 2018;9:191–199. doi:10.1007/s41999-018-0030-x
   PubMed Web of Science ®Google Scholar
• Stevenson JM, Williams JL, Burnham TG, et al. Predicting adverse drug reactions in older adults; a systematic review of the risk prediction models. Clin Interv Aging. 2014;9:1581. doi:10.2147/CIA.S65475
   PubMed Web of Science ®Google Scholar
• Ogoina D, Obiako RO, Muktar HM, et al. Morbidity and mortality patterns of hospitalised adult HIV/AIDS patients in the era of highly active antiretroviral therapy: a 4-year retrospective review from Zaria, Northern Nigeria. AIDS Res Treat. 2012;2012:940580. doi:10.1155/2012/940580
   PubMedGoogle Scholar
• Namme Luma H, Doualla M-S, Choukem S-P, et al. Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study. Pan Afr Med J. 2012;12:87.
   PubMedGoogle Scholar
• Yadesa TM, Kitutu FE, Tamukong R, Alele PE. Prevalence, incidence, and characteristics of adverse drug reactions among older adults hospitalized at mbarara regional referral Hospital, Uganda: a prospective cohort study. Clin Interv Aging. 2021;16:1705–1721. doi:10.2147/CIA.S332251
   PubMed Web of Science ®Google Scholar
• Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29–36. doi:10.1148/radiology.143.1.7063747
   PubMed Web of Science ®Google Scholar
• Committee Joint Formulary. British National Formulary; 2019.
   Google Scholar
• UpToDate Contributors. UpToDate 2021;Version 23; 2021.
   Google Scholar
• American Geriatrics Society. Updated AGS beers criteria® for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–694. doi:10.1111/jgs.15767
   PubMed Web of Science ®Google Scholar
• Bergman-Evans B, Adams S, Titler MG. Improving medication management for older adult clients. J Gerontol Nurs. 2006;32(7):6–14.
   PubMed Web of Science ®Google Scholar
• Jones BA. Decreasing polypharmacy in clients most at risk. AACN Adv Crit Care. 1997;8(4):627–634.
   Google Scholar
• Preskorn SH. Multiple medication use in patients seen in the veterans affairs healthcare system: so what? J Psychiatric Pract. 2005;11(1):46–50. doi:10.1097/00131746-200501000-00006
   PubMedGoogle Scholar
• O’Mahony D, Gallagher P, O’Connor MN, Byrne S. Adverse drug reactions in older patients during hospitalisation: are they predictable? Age Ageing. 2012;41(6):771–776. doi:10.1093/ageing/afs046
   PubMed Web of Science ®Google Scholar
• Bushardt RL, Massey EB, Simpson TW, Ariail JC, Simpson KN. Polypharmacy: misleading, but manageable. Clin Interv Aging. 2008;3(2):383. doi:10.2147/CIA.S2468
   PubMed Web of Science ®Google Scholar
• World Health Organisation. WHO Collaborating Centre for Drug Statistics Methodology. Available from: https://www.whocc.no/atc_ddd_index/. Accessed May 18, 2021.
   Google Scholar
• Meng J, Zhang JX, Pu Y. Quantification of the independent prognostic value of Charlson Comorbidity Index among patients with non-small cell lung cancer. J Clin Oncol. 2018;36(15_suppl):e21164–e21164. doi:10.1200/JCO.2018.36.15_suppl.e21164
   Web of Science ®Google Scholar
• World Health Organisation. ICD-11 for mortality and morbidity statistics. Available from: https://icd.who.int/browse11/l-m/en. Accessed November 16, 2021.
   Google Scholar
• Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. The Lancet. 2000;356(9237):1255–1259. doi:10.1016/S0140-6736(00)02799-9
   PubMed Web of Science ®Google Scholar
• Handler SM, Hanlon JT, Perera S, Roumani YF, Nace DA. Consensus list of signals to detect potential adverse drug reactions in nursing homes. J Am Geriatr Soc. 2008;56:808–815. doi:10.1111/j.1532-5415.2008.01665.x
   PubMed Web of Science ®Google Scholar
• Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–245. doi:10.1038/clpt.1981.154
   PubMed Web of Science ®Google Scholar
• Association WM. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull World Health Organ. 2001;79(4):373.
   PubMed Web of Science ®Google Scholar
• Kojima T, Matsui T, Suzuki Y, et al. Risk factors for adverse drug reactions in older inpatients of geriatric wards at admission: multicenter study. Geriatr Gerontol Int. 2019;20(2):144.
   PubMed Web of Science ®Google Scholar
• Conforti A, Costantini D, Zanetti F, Moretti U, Grezzana M, Leone R. Adverse drug reactions in older patients: an Italian observational prospective hospital study. Drug Healthc Patient Saf. 2012;4:75–80. doi:10.2147/DHPS.S29287
   PubMedGoogle Scholar
• Rawat RS. Evaluation of potentially inappropriate medication use and risk of adverse drug reactions in hospitalized older adults: an observational study in a tertiary care hospital. Int J Pharm Res. 2018;11(2):79–85.
   Google Scholar
• Sneha SG, Simhadri K, Subeesh VK, Sneha SV. Predictors of adverse drug reactions in geriatric patients: an exploratory study among cancer patients. South Asian j Cancer. 2019;8(2):130. doi:10.4103/sajc.sajc_218_18
   PubMed Web of Science ®Google Scholar
• Harugeri APG, Ramesh M, Guido S, Basavanagowdappa H. Frequency and nature of adverse drug reactions in elderly in-patients of two Indian medical college hospitals. J Postgrad Med [serial online]. 2011;57(3):189–195.
   PubMed Web of Science ®Google Scholar
• Ahmed B, Nanji K, Mujeeb R, Patel MJ. Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: a prospective cohort study. PLoS One. 2014;9(11):e112133. doi:10.1371/journal.pone.0112133
   PubMed Web of Science ®Google Scholar
• Tangiisuran B, Davies J, Wright J, Rajkumar C. Adverse drug reactions in a population of hospitalized very elderly patients. Drugs Aging. 2012;29:669–679.
   PubMed Web of Science ®Google Scholar
• Liao P-J, Mao C-T, Chen T-L, Deng S-T, Hsu K-H. Factors associated with adverse drug reaction occurrence and prognosis, and their economic impacts in older inpatients in Taiwan: a nested case–control study. BMJ Open. 2019;9(5):e026771. doi:10.1136/bmjopen-2018-026771
   PubMed Web of Science ®Google Scholar
• Parekh N, Ali K, Stevenson JM, et al. Incidence and cost of medication harm in older adults following hospital discharge: a multicentre prospective study in the UK. Br J Clin Pharmacol. 2018;84(8):1789–1797. doi:10.1111/bcp.13613
   PubMed Web of Science ®Google Scholar
• Najjar M, Abd. Aziz N, Hassan Y, et al. Predictors of polypharmacy and adverse drug reactions among geriatric in patients at Malaysian hospital. Healthmed. 2010;4:273.
   Google Scholar
• Harugeri A, Parthasarathi G, Madhan R, Guido S, Basavanagowdappa H. Frequency and nature of adverse drug reactions in elderly in-patients of two Indian medical college hospitals. J Postgrad Med. 2011;57:189–195. doi:10.4103/0022-3859.85201
   PubMed Web of Science ®Google Scholar
• Alhawassi TM, Krass I, Pont LG. Prevalence and risk factors for adverse drug reactions in older adults in the acute care setting. Pharmacoepidemiol Drug Saf. 2015;24(Suppl. 1):91.
   Google Scholar
• Sikdar KC, Dowden J, Alaghehbandan R, MacDonald D, Peter P, Gadag V. Adverse drug reactions in elderly hospitalized patients: a 12-year population-based retrospective cohort study. Ann Pharmacother. 2012;46(7–8):960–971. doi:10.1345/aph.1Q529
   PubMed Web of Science ®Google Scholar
• Lavan A, Eustace J, Dahly D, et al. Incident adverse drug reactions in geriatric inpatients: a multicentred observational study. Ther Advan Drug Saf. 2018;9(1):13–23. doi:10.1177/2042098617736191
   PubMed Web of Science ®Google Scholar